Simplex Trading, LLC Nymox Pharmaceutical Corp Transaction History

Simplex Trading, LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$0.22 - $0.61 $877 - $2,433	-3,990 Reduced 78.19%	1,113 $0
Q2 2022 Aug 03, 2022	SELL	$0.38 - $1.41 $1,718 - $6,377	-4,523 Reduced 46.99%	5,103 $2,000
Q1 2022 May 02, 2022	SELL	$1.21 - $2.0 $8,179 - $13,520	-6,760 Reduced 41.25%	9,626 $12,000
Q4 2021 Feb 23, 2022	BUY	$0.95 - $2.1 $8,557 - $18,916	9,008 Added 122.09%	16,386 $21,000
Q2 2021 Aug 12, 2021	BUY	$1.46 - $2.48 $2,752 - $4,674	1,885 Added 34.32%	7,378 $11,000
Q1 2021 Apr 26, 2021	BUY	$2.22 - $3.39 $10,058 - $15,360	4,531 Added 471.0%	5,493 $12,000
Q4 2020 Feb 02, 2021	SELL	$1.84 - $2.83 $4,850 - $7,459	-2,636 Reduced 73.26%	962 $2,000
Q3 2020 Oct 14, 2020	SELL	$2.3 - $3.66 $1,147 - $1,826	-499 Reduced 12.18%	3,598 $8,000
Q2 2020 Jul 13, 2020	SELL	$2.1 - $4.6 $8,788 - $19,251	-4,185 Reduced 50.53%	4,097 $14,000
Q1 2020 Apr 29, 2020	BUY	$1.69 - $3.88 $13,996 - $32,134	8,282 New	8,282 $19,000
Q4 2018 Jan 16, 2019	SELL	$1.31 - $2.53 $157,557 - $304,290	-120,273 Closed	0 $0
Q3 2018 Oct 23, 2018	BUY	$2.46 - $3.7 $131,346 - $197,554	53,393 Added 79.83%	120,273 $295,000
Q2 2018 Jul 30, 2018	BUY	$3.12 - $4.33 $178,548 - $247,792	57,227 Added 592.84%	66,880 $224,000
Q1 2018 Apr 26, 2018	SELL	$3.09 - $4.43 $127,156 - $182,298	-41,151 Reduced 81.0%	9,653 $40,000
Q4 2017 Jan 10, 2018	BUY	$3.29 - $4.06 $150,889 - $186,203	45,863 Added 928.21%	50,804 $167,000
Q3 2017 Oct 25, 2017	BUY	$3.36 - $4.02 $16,601 - $19,862	4,941	4,941 $18,000

150K

Ticker NYMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,265,000
Market Cap $42.9M
Description
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.